Table 3:

95–95–95 outcomes by age and sex in the 2015−16 and 2020−21 Malawi Population-based HIV Impact Assessments

	Women				Men
	2015–16	2020–21	Risk ratio between surveys (95% CI)	p value	2015–16	2020–21	Risk ratio between surveys (95% CI)	p value
First 95: awareness
Age 15–24 years	101/170 (57·6%)	115/150 (75·8%)	1·32 (1·08–1·60)	0·0070	20/44 (44·6%)	38/51 (77·2%)	1·73 (1·14–2·64)	0·013
Age 25–49 years	956/1151 (83·0%)	1113/1205 (91·6%)	1·10 (1·06–1·14)	<0·0001	360/513 (71·7%)	395/465 (83·6%)	1·17 (1·08–1·26)	<0·0001
Age ≥50 years	153/184 (81·8%)	245/259 (94·0%)	1·15 (1·05–1·25)	0·0030	130/155 (82·3%)	190/207 (91·1%)	1·11 (1·00–1·22)	0·050
Second 95: on antiretroviral therapy
Age 15–24 years	89/101 (87·9%)	111/115 (96·2%)	1·09 (1·00–1·20)	0·061	17/20 (78·7%)	36/38 (95·4%)	1·21 (0·92–1·59)	0·16
Age 25–49 years	879/956 (93·0%)	1093/1113 (98·1%)	1·05 (1·03–1·08)	<0·0001	311/360 (87·4%)	387/395 (97·2%)	1·11 (1·06–1·17)	<0·0001
Age ≥50 years	142/153 (95·0%)	242/245 (98·9%)	1·04 (1·00–1·08)	0·034	126/130 (95·7%)	186/190 (97·9%)	1·02 (0·97–1·08)	0·41
Third 95: viral load suppression
Age 15–24 years	72/89 (81·4%)	100/111 (90·7%)	1·11 (0·96–1·30)	0·16	14/17 (80·8%)	32/36 (90·6%)	1·12 (0·85–1·49)	0·41
Age 25–49 years	811/879 (92·6%)	1063/1093 (97·2%)	1·05 (1·02–1·08)	0·0010	281/311 (90·0%)	376/387 (97·2%)	1·08 (1·03–1·13)	0·0030
Age ≥50 years	137/142 (94·9%)	240/242 (99·3%)	1·05 (0·99–1·10)	0·089	113/126 (90·8%)	181/186 (97·3%)	1·07 (1·00–1·15)	0·039